Belite Bio annual capital expenditures (capex)
2021
2022
2023
2024
2025
Belite Bio Capital Expenditures (CapEx) Growth & History (BLTE)
Belite Bio's capital expenditures (capex) was $71,000 for fiscal 2025.
View full Belite Bio company overviewBelite Bio annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $71,000 | −$45,000 | −38.79% |
| 2024 | 2024-12-31 | $116,000 | $53,000 | +84.13% |
| 2023 | 2023-12-31 | $63,000 | −$331,000 | −84.01% |
| 2022 | 2022-12-31 | $394,000 | $320,000 | +432.43% |
| 2021 | 2021-12-31 | $74,000 | — | — |
Belite Bio quarterly capital expenditures (capex)
Q4.24
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $6,000 | — | — |
Belite Bio capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Belite Bio's capital expenditures (capex) decreased from $74,000 to $71,000, a change of −$3,000. The latest reported quarter, Q4 2024, shows $6,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Belite Bio source filings ↗